A randomized waitlist-controlled pilot trial of voice over Internet protocol-delivered behavior therapy for youth with chronic tic disorders

A randomized waitlist-controlled pilot trial of voice over Internet protocol-delivered behavior therapy for youth with chronic tic disorders
复制标题

DOI:
10.1177/1357633x15593192
复制
发表时间:
2016-04-01
影响因子:
4.7
通讯作者:
Woods, Douglas W.
Woods, Douglas W.
中科院分区:
医学3区
文献类型:
--
作者:
Ricketts, Emily J.;Goetz, Amy R.;Woods, Douglas W.

文献摘要

被引文献

相似文献

简介:抽动综合行为干预(CBIT)已被证明对慢性抽动障碍(CTD)有效,但由于缺乏治疗提供者以及往返治疗的经济和时间负担,使用受到限制。一个有前途的替代亲自交付是互联网协议语音(VoIP),允许远程,实时治疗交付到病人的家。然而,人们对VoIP对CTD的有效性知之甚少。因此,本研究探讨了初步的有效性,可行性和可接受性的VoIP提供CBIT(CBIT-VoIP)。方法:20名青年(8-16岁)与CTD参加了一个随机的,等待名单控制的试点试验CBIT-VoIP。主要结局是治疗前后临床医师评定的抽动严重程度(耶鲁抽动严重程度量表)的变化。次要结果是临床应答率(临床全球即时改善量表),使用“非常改善”或“大大改善”表示积极的治疗respons.Results:意向治疗分析与最后一次观察结转进行评估。在治疗后(10周),临床医生评定的降低显著更大,(F(1,18)= 3.05,p
Introduction: Comprehensive Behavioral Intervention for Tics (CBIT) has been shown to be efficacious for chronic tic disorders (CTDs), but utilization is limited by a lack of treatment providers and perceived financial and time burden of commuting to treatment. A promising alternative to in-person delivery is voice over Internet protocol (VoIP), allowing for remote, real-time treatment delivery to patients' homes. However, little is known about the effectiveness of VoIP for CTDs. Therefore, the present study examined the preliminary efficacy, feasibility, and acceptability of VoIP-delivered CBIT (CBIT-VoIP).Methods: Twenty youth (8-16 years) with CTDs participated in a randomized, waitlist-controlled pilot trial of CBIT-VoIP. The main outcome was pre- to post-treatment change in clinician-rated tic severity (Yale Global Tic Severity Scale). The secondary outcome was clinical responder rate (Clinical Global Impressions - Improvement Scale), assessed using ratings of 'very much improved' or 'much improved' indicating positive treatment response.Results: Intention-to-treat analyses with the last observation carried forward were performed. At post-treatment (10-weeks), significantly greater reductions in clinician-rated, (F(1,18) = 3.05, p